# OnCo record gna13 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/gna13/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "gna13" ;
  schema:name "GNA13"@en ;
  schema:alternateName "G protein subunit alpha 13"@en, "Guanine nucleotide-binding protein subunit alpha-13"@en, "G13"@en, "MGC46138"@en, "GNA13" ;
  schema:description "GNA13 (Guanine nucleotide-binding protein subunit alpha-13) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as an oncogene driver, a tumour suppressor and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Bladder & urothelial cancer, Non-Hodgkin lymphoma, Diffuse large B-cell lymphoma and 1 more."@en ;
  schema:url <https://onco.cc/targets/gna13/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4381>, <https://www.uniprot.org/uniprotkb/Q14344/entry>, <https://www.ncbi.nlm.nih.gov/gene/10672>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120063> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "tumor-suppressor" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4381>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120063>, <https://www.uniprot.org/uniprotkb/Q14344/entry>, <https://www.ncbi.nlm.nih.gov/gene/10672> ;
  onco:related <https://onco.cc/collections/civic/>, <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/burkitt-lymphoma/> .
